Acute respiratory distress syndrome (ARDS) is a potentially fatal condition where the lungs cannot provide enough oxygen to the body's vital organs. The condition, otherwise known as acute lung injury ...
Adjunct corticosteroids probably reduce short-term mortality in adults with severe pneumonia or acute respiratory distress ...
In the base-case scenario, I estimate that of the 141,500 annual ARDS cases in the USA, 16,980 may be attributable to allogeneic pRBC transfusion ( Table 1). Multiplying this number by the average per ...
The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across the ...
Wilmington, Delaware, United States, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The acute respiratory distress syndrome devices market was estimated to have acquired US$ 311.1 million in 2021. It is ...
The body’s immune system works by protecting against disease and potentially damaging foreign bodies. In some instances, it may become impaired, leading to overreaction to infection. Sepsis is a ...
New York, United States , April 03, 2023 (GLOBE NEWSWIRE) -- The Global Acute Respiratory Distress Syndrome Market Size to grow from USD 980.4 million in 2021 to USD 2,137.6 million by 2030, at a ...
Corticosteroids, known as synthetic hormones, when used for severe pneumonia (non-COVID) can reduce all-cause mortality, and ...
Data Bridge Market research has a newly released expansive study titled “North America Acute Respiratory Distress Syndrome (ARDS) Market ” which guarantees you will remain better informed than your ...
DelveInsight's'Acute Respiratory Distress Syndrome - Market Insights, Epidemiology and Market Forecast-2023'report provides an overview of the Acute Respiratory Distress Syndrome along with the ...
Acute respiratory distress syndrome, also known as ARDS, is a common killer among critically ill patients hospitalized with COVID-19. But even if they survive, it’s a long road to recovery. Patients ...